Compile Data Set for Download or QSAR
maximum 50k data
Found 682 with Last Name = 'phuong' and Initial = 'vk'
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50412863(CHEMBL359632 | JNJ-10397049)
Affinity DataKi:  5nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415082(CHEMBL583035)
Affinity DataKi:  5.01nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415081(CHEMBL571650)
Affinity DataKi:  5.01nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50412861(CHEMBL185088)
Affinity DataKi:  6.30nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415083(CHEMBL566574)
Affinity DataKi:  6.31nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415080(CHEMBL585157)
Affinity DataKi:  6.31nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415077(CHEMBL584525)
Affinity DataKi:  10nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415084(CHEMBL565324)
Affinity DataKi:  10nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415079(CHEMBL569391)
Affinity DataKi:  10nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415078(CHEMBL565298)
Affinity DataKi:  10nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415053(CHEMBL583457)
Affinity DataKi:  12.6nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415085(CHEMBL570520)
Affinity DataKi:  12.6nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415066(CHEMBL585914)
Affinity DataKi:  15.8nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415066(CHEMBL585914)
Affinity DataKi:  15.8nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50412862(CHEMBL185136)
Affinity DataKi:  20nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196190(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi:  25nMAssay Description:Displacement of [125I]CCK-8S from CCK2 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50474855(CHEMBL364814)
Affinity DataKi:  25nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196190(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi:  25nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415058(CHEMBL571206)
Affinity DataKi:  25.1nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415076(CHEMBL583344)
Affinity DataKi:  25.1nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415052(CHEMBL583343)
Affinity DataKi:  31.6nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196191(4-[4-iodo-2-[(5-quinoxalinylsulfonyl)amino]benzoyl...)
Affinity DataKi:  32nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415068(CHEMBL569470)
Affinity DataKi:  39.8nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196157(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi:  40nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50412860(CHEMBL185093)
Affinity DataKi:  40nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50474849(CHEMBL185424)
Affinity DataKi:  50nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415072(CHEMBL565511)
Affinity DataKi:  50.1nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50412857(CHEMBL361716)
Affinity DataKi:  63nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478086(CHEMBL261682)
Affinity DataKi:  63nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50412859(CHEMBL182473)
Affinity DataKi:  63nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415064(CHEMBL584259)
Affinity DataKi:  63.1nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415074(CHEMBL566604)
Affinity DataKi:  63.1nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50474846(CHEMBL185131)
Affinity DataKi:  79nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50474848(CHEMBL184596)
Affinity DataKi:  79nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50412855(CHEMBL185382)
Affinity DataKi:  79nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478090(CHEMBL259762)
Affinity DataKi:  79nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50412854(CHEMBL185435)
Affinity DataKi:  79nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415061(CHEMBL570521)
Affinity DataKi:  79.4nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415062(CHEMBL566390)
Affinity DataKi:  79.4nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415051(CHEMBL584063)
Affinity DataKi:  79.4nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415051(CHEMBL584063)
Affinity DataKi:  79.4nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415067(CHEMBL566359)
Affinity DataKi:  79.4nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415071(CHEMBL566360)
Affinity DataKi:  100nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50474847(CHEMBL183421)
Affinity DataKi:  100nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50412849(CHEMBL363743)
Affinity DataKi:  100nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415077(CHEMBL584525)
Affinity DataKi:  100nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50412851(CHEMBL363951)
Affinity DataKi:  100nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50415085(CHEMBL570520)
Affinity DataKi:  126nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50412858(CHEMBL183576)
Affinity DataKi:  126nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50474855(CHEMBL364814)
Affinity DataKi:  126nMAssay Description:Binding affinity towards human orexin receptor type 1 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 682 total ) | Next | Last >>
Jump to: